Showing results (41-50 of 171) with videos related to
Sort By:
Pageof 18
Scientific Reports|March 29, 2017
The VPS4 component of the ESCRT machinery plays an essential role in HPV infectious entry and capsid disassemblyJustyna Broniarczyk, David Pim, Paola Massimi, et al.Expert Opinion on Therapeutic Targets|October 8, 2013
HPV E6 oncoprotein as a potential therapeutic target in HPV related cancersJoaquin Manzo-Merino, Miranda Thomas, Alma M Fuentes-Gonzalez, et al.Plos Pathogens|August 19, 2016
A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin ReceptorMojgan Padash Barmchi, Mary Gilbert, Miranda Thomas, et al.Experimental Cell Research|September 17, 2008
Regulation of the hDlg/hScrib/Hugl-1 tumour suppressor complexPaola Massimi, Nisha Narayan, Miranda Thomas, et al.Oncogene|July 26, 2002
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradationMiranda Thomas, Richard Laura, Karin Hepner, et al.Journal of Virology|February 3, 2007
Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoproteinYi Zhang, Jhimli Dasgupta, Runlin Z Ma, et al.Journal of Cellular and Molecular Medicine|December 22, 2018
Oncogenic comparison of human papillomavirus type 58 E7 variantsPriscilla Ty Law, Siaw Shi Boon, Chenghua Hu, et al.Journal of Virology|April 19, 2019
Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious EntryJustyna Broniarczyk, Paola Massimi, David Pim, et al.Virology|November 13, 2007
Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancerPaola Massimi, Miranda Thomas, Veronique Bouvard, et al.Viruses|August 26, 2022
CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer CellsAilyn C Ramón, Om Basukala, Paola Massimi, et al.Pageof 18